USE OF LOPINAVIR/RITONAVIR ASSOCIATED WITH ERGOTAMINE RESULTING IN FOOT AMPUTATION: BRIEF COMMUNICATION

A 32-year-old female, was diagnosed in 2004 with a C1 HIV1 infection, using zidovudine/lamivudine 300/150 mg BID and lopinavir/ritonavir 400/100 mg BID, in addition to prophylaxis with trimethoprim-sulfamethoxazole 800/160 mg QD, but no prophylaxis with macrolide antibiotics. The patient presented w...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferry, Fernando Raphael de Almeida, Silva, Guilherme Almeida Rosa Da, Motta, Rogerio Neves, Carvalho, Ricardo de Souza, Sá, Carlos Alberto Morais De
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto de Medicina Tropical 2014
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4085857/
https://www.ncbi.nlm.nih.gov/pubmed/24879006
http://dx.doi.org/10.1590/S0036-46652014000300013
_version_ 1782324719108751360
author Ferry, Fernando Raphael de Almeida
Silva, Guilherme Almeida Rosa Da
Motta, Rogerio Neves
Carvalho, Ricardo de Souza
Sá, Carlos Alberto Morais De
author_facet Ferry, Fernando Raphael de Almeida
Silva, Guilherme Almeida Rosa Da
Motta, Rogerio Neves
Carvalho, Ricardo de Souza
Sá, Carlos Alberto Morais De
author_sort Ferry, Fernando Raphael de Almeida
collection PubMed
description A 32-year-old female, was diagnosed in 2004 with a C1 HIV1 infection, using zidovudine/lamivudine 300/150 mg BID and lopinavir/ritonavir 400/100 mg BID, in addition to prophylaxis with trimethoprim-sulfamethoxazole 800/160 mg QD, but no prophylaxis with macrolide antibiotics. The patient presented with a severe headache and was prescribed two capsules of the anti-migraine drug Ormigrein™, which contained ergotamine tartrate 1 mg, caffeine 100 mg, paracetamol 220 mg, hyoscyamine sulfate 87.5 mcg, and atropine sulfate 12.5 mcg. Afterwards she was prescribed one capsule of Ormigrein every 30 minutes for a total of six capsules a day. The patient took the medication as prescribed but developed a pain in her left ankle three days later, which evolved to the need for amputation.
format Online
Article
Text
id pubmed-4085857
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Instituto de Medicina Tropical
record_format MEDLINE/PubMed
spelling pubmed-40858572014-07-16 USE OF LOPINAVIR/RITONAVIR ASSOCIATED WITH ERGOTAMINE RESULTING IN FOOT AMPUTATION: BRIEF COMMUNICATION Ferry, Fernando Raphael de Almeida Silva, Guilherme Almeida Rosa Da Motta, Rogerio Neves Carvalho, Ricardo de Souza Sá, Carlos Alberto Morais De Rev Inst Med Trop Sao Paulo Brief Communication A 32-year-old female, was diagnosed in 2004 with a C1 HIV1 infection, using zidovudine/lamivudine 300/150 mg BID and lopinavir/ritonavir 400/100 mg BID, in addition to prophylaxis with trimethoprim-sulfamethoxazole 800/160 mg QD, but no prophylaxis with macrolide antibiotics. The patient presented with a severe headache and was prescribed two capsules of the anti-migraine drug Ormigrein™, which contained ergotamine tartrate 1 mg, caffeine 100 mg, paracetamol 220 mg, hyoscyamine sulfate 87.5 mcg, and atropine sulfate 12.5 mcg. Afterwards she was prescribed one capsule of Ormigrein every 30 minutes for a total of six capsules a day. The patient took the medication as prescribed but developed a pain in her left ankle three days later, which evolved to the need for amputation. Instituto de Medicina Tropical 2014 /pmc/articles/PMC4085857/ /pubmed/24879006 http://dx.doi.org/10.1590/S0036-46652014000300013 Text en http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Communication
Ferry, Fernando Raphael de Almeida
Silva, Guilherme Almeida Rosa Da
Motta, Rogerio Neves
Carvalho, Ricardo de Souza
Sá, Carlos Alberto Morais De
USE OF LOPINAVIR/RITONAVIR ASSOCIATED WITH ERGOTAMINE RESULTING IN FOOT AMPUTATION: BRIEF COMMUNICATION
title USE OF LOPINAVIR/RITONAVIR ASSOCIATED WITH ERGOTAMINE RESULTING IN FOOT AMPUTATION: BRIEF COMMUNICATION
title_full USE OF LOPINAVIR/RITONAVIR ASSOCIATED WITH ERGOTAMINE RESULTING IN FOOT AMPUTATION: BRIEF COMMUNICATION
title_fullStr USE OF LOPINAVIR/RITONAVIR ASSOCIATED WITH ERGOTAMINE RESULTING IN FOOT AMPUTATION: BRIEF COMMUNICATION
title_full_unstemmed USE OF LOPINAVIR/RITONAVIR ASSOCIATED WITH ERGOTAMINE RESULTING IN FOOT AMPUTATION: BRIEF COMMUNICATION
title_short USE OF LOPINAVIR/RITONAVIR ASSOCIATED WITH ERGOTAMINE RESULTING IN FOOT AMPUTATION: BRIEF COMMUNICATION
title_sort use of lopinavir/ritonavir associated with ergotamine resulting in foot amputation: brief communication
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4085857/
https://www.ncbi.nlm.nih.gov/pubmed/24879006
http://dx.doi.org/10.1590/S0036-46652014000300013
work_keys_str_mv AT ferryfernandoraphaeldealmeida useoflopinavirritonavirassociatedwithergotamineresultinginfootamputationbriefcommunication
AT silvaguilhermealmeidarosada useoflopinavirritonavirassociatedwithergotamineresultinginfootamputationbriefcommunication
AT mottarogerioneves useoflopinavirritonavirassociatedwithergotamineresultinginfootamputationbriefcommunication
AT carvalhoricardodesouza useoflopinavirritonavirassociatedwithergotamineresultinginfootamputationbriefcommunication
AT sacarlosalbertomoraisde useoflopinavirritonavirassociatedwithergotamineresultinginfootamputationbriefcommunication

Ejemplares similares